Shushan Hovsepyan, Editor in Chief of the OncoDaily Medical Journal, shared on Linkedin:
”It was a pleasure to attend the session where Ruzanna Papyan presented on the accessibility of Anti-GD2 antibody therapy at SIOP 2024 in Honolulu.
This is super important topic. We should understand how we can overcome barriers and expand access to this life-saving treatment for children globally.”
